AstraZeneca Pharma Board approves issue of non-convertible bonus debentures

AstraZeneca Pharma India Ltd has announced that the Board of Directors of the Company at its meeting held on September 08, 2006 has approved the Scheme of Arrangement between the Company and its shareholders for issue of secured fully paid redeemable non-convertible bonus debentures from the Company’s General Reserve, subject to the same being approved by the shareholders and creditors of the Company as required by section 391 of the Companies Act, 1956 and the same being sanctioned by the Karnataka High Court under section 391 of the said Act and the obtaining of such other approvals as may be required.

Source : Equity Bulls

Keywords